Related references
Note: Only part of the references are listed.Anti-Parkinsonian Effects of Nurr1 Activator in Ubiquitin-Proteasome System Impairment Induced Animal Model of Parkinson's Disease
Zhen Zhang et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2012)
Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease
M. Decressac et al.
EXPERIMENTAL NEUROLOGY (2012)
MicroRNA-124 Is a Subventricular Zone Neuronal Fate Determinant
Malin Akerblom et al.
JOURNAL OF NEUROSCIENCE (2012)
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons
M. Decressac et al.
NEUROBIOLOGY OF DISEASE (2012)
Impaired neurotransmission caused by overexpression of α-synuclein in nigral dopamine neurons
Martin Lundblad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease
Mickael Decressac et al.
BRAIN (2011)
The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS
Michele M. Maxwell et al.
HUMAN MOLECULAR GENETICS (2011)
Signaling of Glial Cell Line-Derived Neurotrophic Factor and Its Receptor GFRα1 Induce Nurr1 and Pitx3 to Promote Survival of Grafted Midbrain-Derived Neural Stem Cells in a Rat Model of Parkinson Disease
Zhinian Lei et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Pitx3 Is a Critical Mediator of GDNF-Induced BDNF Expression in Nigrostriatal Dopaminergic Neurons
Changgeng Peng et al.
JOURNAL OF NEUROSCIENCE (2011)
α-Synuclein Negatively Regulates Protein Kinase Cδ Expression to Suppress Apoptosis in Dopaminergic Neurons by Reducing p300 Histone Acetyltransferase Activity
Huajun Jin et al.
JOURNAL OF NEUROSCIENCE (2011)
Increased efficacy of the 6-hydroxydopamine lesion of the median forebrain bundle in small rats, by modification of the stereotaxic coordinates
E. M. Torres et al.
JOURNAL OF NEUROSCIENCE METHODS (2011)
Bioactivity of AAV2-Neurturin Gene Therapy (CERE-120): Differences Between Parkinson's Disease and Nonhuman Primate Brains
Raymond T. Bartus et al.
MOVEMENT DISORDERS (2011)
Parkinson's Disease and α-Synuclein Expression
Michael J. Devine et al.
MOVEMENT DISORDERS (2011)
Priorities in Parkinson's disease research
Wassilios G. Meissner et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
alpha-synuclein aggregation reduces nigral myocyte enhancer Factor-2D in idiopathic and experimental Parkinson's disease
Yaping Chu et al.
NEUROBIOLOGY OF DISEASE (2011)
Exogenous α-Synuclein Fibrils Induce Lewy Body Pathology Leading to Synaptic Dysfunction and Neuron Death
Laura A. Volpicelli-Daley et al.
NEURON (2011)
Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis
Xiaodong Ma et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Repairing the parkinsonian brain with neurotrophic factors
Liviu Aron et al.
TRENDS IN NEUROSCIENCES (2011)
MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells
Lu Jiang et al.
BIOCHEMICAL JOURNAL (2010)
Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153
Epaminondas Doxakis
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
miR-22 Forms a Regulatory Loop in PTEN/AKT Pathway and Modulates Signaling Kinetics
Nadav Bar et al.
PLOS ONE (2010)
NR4A orphan nuclear receptors as mediators of CREB-dependent neuroprotection
Nikolaos Volakakis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
α-Synuclein and dopamine at the crossroads of Parkinson's disease
Lara Lourenco Venda et al.
TRENDS IN NEUROSCIENCES (2010)
Pitx3 potentiates Nurr1 in dopamine neuron terminal differentiation through release of SMRT-mediated repression
Frank M. J. Jacobs et al.
DEVELOPMENT (2009)
Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease
Samareh Azeredo da Silveira et al.
HUMAN MOLECULAR GENETICS (2009)
Dynamic Changes in Presynaptic and Axonal Transport Proteins Combined with Striatal Neuroinflammation Precede Dopaminergic Neuronal Loss in a Rat Model of AAV α-Synucleinopathy
Chee Yeun Chung et al.
JOURNAL OF NEUROSCIENCE (2009)
Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons
Banafsheh Kadkhodaei et al.
JOURNAL OF NEUROSCIENCE (2009)
NUCLEAR AND NEURITIC DISTRIBUTION OF SERINE-129 PHOSPHORYLATED α-SYNUCLEIN IN TRANSGENIC MICE
H. Schell et al.
NEUROSCIENCE (2009)
Characterisation of a novel NR4A2 mutation in Parkinson's disease brain
P. M. A. Sleiman et al.
NEUROSCIENCE LETTERS (2009)
Repression of α-synuclein expression and toxicity by microRNA-7
Eunsung Junn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Absolute requirement of GDNF for adult catecholaminergic neuron survival
Alberto Pascual et al.
NATURE NEUROSCIENCE (2008)
A microRNA feedback circuit in midbrain dopamine neurons
Jongpil Kim et al.
SCIENCE (2007)
Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease
Tiago Fleming Outeiro et al.
SCIENCE (2007)
Distribution and localization patterns of estrogen receptor-O and insulin-like growth factor-1 receptors in neurons and glial cells of the female rat substantia nigra: Localization of ERP and IGF-1R in substantia nigra
Arnulfo Quesada et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
Absence of ret signaling in mice causes progressive and late degeneration of the nigrostriatal system
Edgar R. Kramer et al.
PLOS BIOLOGY (2007)
Accumulation of phosphorylated alpha-synuclein in dopaminergic neurons of transgenic mice that express human alpha-synuclein
Masaki Wakamatsu et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2007)
Age-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease?
Yaping Chu et al.
NEUROBIOLOGY OF DISEASE (2007)
RET is dispensable for maintenance of midbrain dopaminergic neurons in adult mice
Sanjay Jain et al.
JOURNAL OF NEUROSCIENCE (2006)
α-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity
Eirene Kontopoulos et al.
HUMAN MOLECULAR GENETICS (2006)
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease
AE Lang et al.
ANNALS OF NEUROLOGY (2006)
Crossroads in GDNF therapy for Parkinson's disease
TB Sherer et al.
MOVEMENT DISORDERS (2006)
Nurr1 in Parkinson's disease and related disorders
YP Chu et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2006)
Localized striatal delivery of GDNF as a treatment for Parkinson disease
D Kirik et al.
NATURE NEUROSCIENCE (2004)
Lentiviral nigral delivery of GDNF does not prevent neurodegeneration in a genetic rat model of Parkinson's disease
C Lo Bianco et al.
NEUROBIOLOGY OF DISEASE (2004)
Nuclear localization of α-synuclein and its interaction with histones
J Goers et al.
BIOCHEMISTRY (2003)
Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease
SS Gill et al.
NATURE MEDICINE (2003)
Mutations in NR4A2 associated with familial Parkinson disease
WD Le et al.
NATURE GENETICS (2003)
Type 2 diabetes in childhood: The American perspective
I Libman et al.
HORMONE RESEARCH (2003)
Production methods for gene transfer vectors based on adeno-associated virus serotypes
D Grimm
METHODS (2002)
Towards a neuroprotective gene therapy for Parkinson's disease:: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model
A Björklund et al.
BRAIN RESEARCH (2000)
Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
JH Kordower et al.
SCIENCE (2000)
Share Paper
